PATENT CLAIM ANALYSIS

Application Number: 16280603
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "005900"]

Abstract:
The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.

Claim (Index 9):
A method of treating a metabolic disorder, comprising administering the pharmaceutical composition according to  claim 1  to a subject in need thereof.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 99.0
- Lexical Diversity: 1.44444
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16023328', '15121206', '15023872', '14391510', '12673226']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.750531635366515
- 35 USC 102 Novelty (BERT): 0.7524727174243199
- Combined Prediction Score: 0.7507257435722955
- Mean Citation Score: 402.906832
- Max Citation Score: 847.4852
- Similarity Product: 687.6046821617603

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test